Feb 22, 2019 - BMO Capital Markets issues rating change for BIIB
Feb 11, 2019 - AbbVie missed its Q4 earnings expectations, but it does have many other products to help it get back on track in the coming quarters.The big loss for the quarter was due to international sales of Humi
Feb 08, 2019 - Top Research Reports for Visa, Charter Communications & Biogen
Feb 04, 2019 -
Jan 30, 2019 -
Ionis Pharmaceuticals Inc (NASDAQ: IONS)'s partner Biogen Inc (NASDAQ: BIIB) reported
Jan 29, 2019 -
Jan 29, 2019 - BIIB earnings call for the period ending December 31, 2018.
Jan 29, 2019 - Biogen (BIIB) beats estimates for both earnings and sales in the fourth quarter of 2018, driven by higher sales of Spinraza.
Jan 29, 2019 - The following slide deck was published by Biogen Inc. in conjunction with their 2018 Q4 earnings call.
Jan 28, 2019 - Biogen’s largest revenue driver, its multiple sclerosis franchise, has seen stagnant growth and has a bleak future ahead.Its new drug Spinraza is growing strong but faces severe impending competition